CYTOKINES CONTRIBUTE TO AIRWAY DYSFUNCTION IN ANTIGEN-CHALLENGED GUINEA-PIGS - INHIBITION OF AIRWAY HYPERREACTIVITY, PULMONARY EOSINOPHIL ACCUMULATION, AND TUMOR-NECROSIS-FACTOR GENERATION BY PRETREATMENT WITH AN INTERLEUKIN-1 RECEPTOR ANTAGONIST

被引:113
作者
WATSON, ML [1 ]
SMITH, D [1 ]
BOURNE, AD [1 ]
THOMPSON, RC [1 ]
WESTWICK, J [1 ]
机构
[1] SYNERGEN,BOULDER,CO
基金
英国惠康基金;
关键词
D O I
10.1165/ajrcmb/8.4.365
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of pro-inflammatory cytokines in an animal model of allergic lung disease was examined by use of an interleukin-1 receptor antagonist (IL-1ra) and a specific bioassay for tumor necrosis factor (TNF). Ovalbumin-sensitized guinea pigs exhibit a marked bronchial hyperreactivity (assessed by airway responsiveness to intravenous histamine) and pulmonary eosinophil accumulation (assessed by bronchoalveolar lavage) 24 h after challenge with aerosolized antigen. Exposure of animals to an aerosol of IL-1ra (50 mug over 30 min) immediately before antigen challenge resulted in a marked protection against bronchial hyperreactivity and pulmonary eosinophil accumulation compared with IL-1ra vehicle-pretreated animals. Additionally, we report for the first time generation of TNF bioactivity in the bronchoalveolar lavage of antigen-challenged animals, which was significantly reduced in animals exposed to aerosolized IL-1ra before challenge. These studies point to a key role for the cytokines IL-1 and possibly TNF in the pulmonary changes observed during allergic airway disease.
引用
收藏
页码:365 / 369
页数:5
相关论文
共 39 条
[1]   INTERLEUKIN-1 IS RELEASED AT SITES OF HUMAN CUTANEOUS ALLERGIC REACTIONS [J].
BOCHNER, BS ;
CHARLESWORTH, EN ;
LICHTENSTEIN, LM ;
DERSE, CP ;
GILLIS, S ;
DINARELLO, CA ;
SCHLEIMER, RP .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 86 (06) :830-839
[2]   INTERLEUKIN-3-DEPENDENT AND INTERLEUKIN-3-INDEPENDENT MAST-CELLS STIMULATED WITH IGE AND ANTIGEN EXPRESS MULTIPLE CYTOKINES [J].
BURD, PR ;
ROGERS, HW ;
GORDON, JR ;
MARTIN, CA ;
JAYARAMAN, S ;
WILSON, SD ;
DVORAK, AM ;
GALLI, SJ ;
DORF, ME .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (01) :245-257
[3]  
BURROWS L J, 1991, Fundamental and Clinical Pharmacology, V5, P405
[4]  
DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373
[5]   PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION FROM COMPLEMENTARY-DNA OF A HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
EISENBERG, SP ;
EVANS, RJ ;
AREND, WP ;
VERDERBER, E ;
BREWER, MT ;
HANNUM, CH ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :341-346
[6]   A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES [J].
ESPEVIK, T ;
NISSENMEYER, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) :99-105
[7]  
FAHERTY DA, 1992, J IMMUNOL, V148, P766
[8]   MAST-CELLS AS A SOURCE OF BOTH PREFORMED AND IMMUNOLOGICALLY INDUCIBLE TNF-ALPHA CACHECTIN [J].
GORDON, JR ;
GALLI, SJ .
NATURE, 1990, 346 (6281) :274-276
[9]   INCREASED SECRETION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 BY ALVEOLAR MACROPHAGES CONSECUTIVE TO THE DEVELOPMENT OF THE LATE ASTHMATIC REACTION [J].
GOSSET, P ;
TSICOPOULOS, A ;
WALLAERT, B ;
VANNIMENUS, C ;
JOSEPH, M ;
TONNEL, AB ;
CAPRON, A .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (04) :561-571
[10]  
GRAZIANO F, 1981, J IMMUNOL, V127, P1067